NFE2L2 and central nervous system cancer: Considering that HACE1 is able to activate NRF2, a key oncoprotein in glioma, under oxidative stress,17,32 thus we determined the regulatory effect of HACE1 on NRF2 activity, attempting to illustrate its oncogenic role in glioma cells.